tiprankstipranks
QuantumPharm, Inc. (HK:2228)
:2228
Hong Kong Market

QuantumPharm, Inc. (2228) Financial Statements

13 Followers

QuantumPharm, Inc. Financial Overview

QuantumPharm, Inc.'s market cap is currently HK$41.29B. The company's EPS TTM is HK$0.01; its P/E ratio is 266.61; QuantumPharm, Inc. is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 781.85M¥ 266.43M¥ 174.42M¥ 133.35M¥ 62.80M
Gross Profit¥ 544.71M¥ 123.43M¥ 48.24M¥ 66.09M¥ 32.78M
Operating Income¥ -496.50M¥ -684.21M¥ -722.31M¥ -525.31M¥ -299.43M
EBITDA¥ -383.89M¥ -631.38M¥ -1.78B¥ -1.38B¥ -2.11B
Net Income¥ 120.54M¥ -1.52B¥ -1.91B¥ -1.44B¥ -2.14B
Balance Sheet
Cash & Short-Term Investments¥ 7.07B¥ 3.10B¥ 2.83B¥ 3.47B¥ 3.83B
Total Assets¥ 10.22B¥ 4.35B¥ 4.01B¥ 4.32B¥ 4.38B
Total Debt¥ 443.46M¥ 148.76M¥ 11.04B¥ 9.45B¥ 7.83B
Net Debt¥ -2.15B¥ -1.02B¥ 10.33B¥ 8.88B¥ 4.31B
Total Liabilities¥ 786.95M¥ 362.43M¥ 11.25B¥ 9.63B¥ 7.99B
Stockholders' Equity¥ 9.39B¥ 3.96B¥ -7.27B¥ -5.33B¥ -3.61B
Cash Flow
Free Cash Flow¥ -199.96M¥ -536.79M¥ -698.20M¥ -627.83M¥ -417.42M
Operating Cash Flow¥ -139.62M¥ -478.68M¥ -567.56M¥ -429.10M¥ -253.75M
Investing Cash Flow¥ -3.87B¥ 74.09M¥ 735.58M¥ -2.76B¥ -70.47M
Financing Cash Flow¥ 5.43B¥ 840.00M¥ -25.89M¥ 57.99M¥ 2.48B
Currency in CNY

QuantumPharm, Inc. Earnings and Revenue History

QuantumPharm, Inc. Debt to Assets

QuantumPharm, Inc. Cash Flow

QuantumPharm, Inc. Forecast EPS vs Actual EPS